Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;21(12):1224-1233.
doi: 10.6004/jnccn.2023.0062.

NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024

Nadeem R Abu-Rustum  1 , Catheryn M Yashar  2 , Rebecca Arend  3 , Emma Barber  4 , Kristin Bradley  5 , Rebecca Brooks  6 , Susana M Campos  7 , Junzo Chino  8 , Hye Sook Chon  9 , Marta Ann Crispens  10 , Shari Damast  11 , Christine M Fisher  12 , Peter Frederick  13 , David K Gaffney  14 , Stephanie Gaillard  15 , Robert Giuntoli  16 , Scott Glaser  17 , Jordan Holmes  18 , Brooke E Howitt  19 , Jayanthi Lea  20 , Gina Mantia-Smaldone  21 , Andrea Mariani  22 , David Mutch  23 , Christa Nagel  24 , Larissa Nekhlyudov  7 , Mirna Podoll  10 , Kerry Rodabaugh  25 , Ritu Salani  26 , John Schorge  27 , Jean Siedel  28 , Rachel Sisodia  29 , Pamela Soliman  30 , Stefanie Ueda  31 , Renata Urban  32 , Emily Wyse  33 , Nicole R McMillian  34 , Shaili Aggarwal  34 , Sara Espinosa  34
Affiliations

NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024

Nadeem R Abu-Rustum et al. J Natl Compr Canc Netw. 2023 Dec.

Abstract

The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.

PubMed Disclaimer

MeSH terms